(CT ± SD) for PAI-1 gene in the drug-naive group (controls) was (27.28 ± 0.66) and in post OCP treated PCOS group (cases) was (26.96 ± 0.78) (p = 0.12). This evidence concerns the gene SERPINE1 and polycystic ovary syndrome.